NCT06574061

Evaluation of the Benefits of Sublingual AIT (PRACTIS)

Evaluation in Routine Practice of the Benefits of Sublingual Allergen Immunotherapy in Allergic Patients According to Different Modalities of Use

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,635 (actual)
• Sponsor: Stallergenes Greer · Industry
• Sex: All
• Age: 5 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study was to evaluate in routine practice the benefits of sublingual allergen immunotherapy (SLIT) for allergic patients with allergic rhinitis (AR), with or without asthma, according to various methods of use (treatment regimen: formulation type, dose, duration, initiation) and type of allergen (grass pollen, tree pollen, herbaceous pollen, house dust mites, animal dander, moulds and poly-reactive types).

Detailed description

The treatment considered was any SLIT (tablet or liquid forms) accepted by the patient and the parent(s) in the case of minor patients. The treatment was taken as prescribed by the observing physician. The expected benefits for patients after approximately 6 and 12 months after initiation of SLIT included: * Decreased intensity of symptoms * Decreased discomfort * Decreased consumption of symptomatic treatments or associated treatments (especially in asthmatic patients) * Improved quality of life * Reduced absenteeism from school or work * Beneficial impact on leisure activities.

Conditions

• Allergic Rhinitis

Timeline

• Start date: 2018-08-29
• Primary completion: 2020-07-22
• Completion: 2021-10-14
• First posted: 2024-08-27
• Last updated: 2024-08-29

Locations

1 site across 1 country: France